Loading…

Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy

Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative...

Full description

Saved in:
Bibliographic Details
Published in:American journal of otolaryngology 2007-03, Vol.28 (2), p.73-77
Main Authors: Gisterek, Iwona, MD, PhD, Sedlaczek, Paweł, PhD, Kornafel, Jan, Harłoziñska-Szmyrka, Antonina, Łacko, Aleksandra, MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33
cites cdi_FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33
container_end_page 77
container_issue 2
container_start_page 73
container_title American journal of otolaryngology
container_volume 28
creator Gisterek, Iwona, MD, PhD
Sedlaczek, Paweł, PhD
Kornafel, Jan
Harłoziñska-Szmyrka, Antonina
Łacko, Aleksandra, MD, PhD
description Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative sandwich enzyme immunoassay technique. Most (25 patients [68%]) of the studied population were found to have high pretreatment VEGF concentration (of >700 pg/mL; median, 796.3 pg/mL). During radiotherapy, after receiving the total dose of 40 Gy, the median level of serum VEGF remained unchanged (795.2 pg/mL). Regardless of the treatment results, 2 months after completing irradiation the median VEGF level decreased to 448.9 pg/mL, and the difference between pre- and posttreatment medians was statistically significant ( P < .05). No association between pretreatment serum VEGF concentrations and the size of tumor, lymph node status, and patients' age was found. The findings that radiotherapy produces serum VEGF decline in primary pharyngeal and laryngeal carcinomas ( P = .065) may be related to the blocking effect of radiation on local angiogenesis.
doi_str_mv 10.1016/j.amjoto.2006.06.015
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70268517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0196070906001232</els_id><sourcerecordid>70268517</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33</originalsourceid><addsrcrecordid>eNqFkluL1DAUx4Mo7jj6DUQCom8dc-klfRGWxRss-LAKvoUz6elOatt0k3SXefeDm9LBgX0RAiHhd27__yHkNWc7znj5odvB0LnodoKxcrccXjwhG15IkSmufj0lG8brMmMVqy_IixA6xpjMZfGcXPBKlkKxekP-3KCfB3oPwcw9eIpj4-IBews9vfXuIR5oCyY6T-1IJ4gWxxjog03_0wH8cbzFRMLY0P7fK9zNMLg5UIN9Tw14Y0c3AI0eIWKzRnto7FLJw3R8SZ610Ad8dbq35OfnTz-uvmbX3798u7q8zkxeyZiBUkqqPBe4byWv0gCNaop9rQSHUiUVSiZVpaSplQGoc5AlJqqqQWFe7KXckvdr3sm7uxlD1IMNS5MwYupXV0yUqkjibMnbR2DnZj-m3jRnkotc8Gqh8pUy3oXgsdWTt0OSIUF68Uh3evVILx7p5SR7tuTNKfm8H7A5B51MScC7E5Bcgb71MBobzlzNVSVFmbiPK4dJs3uLXgeT_DHYWI8m6sbZ_3XyOIHp7WhTzd94xHCeWQehmb5Z9mlZJ1YyxoUU8i9uUsfC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1031242177</pqid></control><display><type>article</type><title>Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy</title><source>ScienceDirect Journals</source><creator>Gisterek, Iwona, MD, PhD ; Sedlaczek, Paweł, PhD ; Kornafel, Jan ; Harłoziñska-Szmyrka, Antonina ; Łacko, Aleksandra, MD, PhD</creator><creatorcontrib>Gisterek, Iwona, MD, PhD ; Sedlaczek, Paweł, PhD ; Kornafel, Jan ; Harłoziñska-Szmyrka, Antonina ; Łacko, Aleksandra, MD, PhD</creatorcontrib><description>Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative sandwich enzyme immunoassay technique. Most (25 patients [68%]) of the studied population were found to have high pretreatment VEGF concentration (of &gt;700 pg/mL; median, 796.3 pg/mL). During radiotherapy, after receiving the total dose of 40 Gy, the median level of serum VEGF remained unchanged (795.2 pg/mL). Regardless of the treatment results, 2 months after completing irradiation the median VEGF level decreased to 448.9 pg/mL, and the difference between pre- and posttreatment medians was statistically significant ( P &lt; .05). No association between pretreatment serum VEGF concentrations and the size of tumor, lymph node status, and patients' age was found. The findings that radiotherapy produces serum VEGF decline in primary pharyngeal and laryngeal carcinomas ( P = .065) may be related to the blocking effect of radiation on local angiogenesis.</description><identifier>ISSN: 0196-0709</identifier><identifier>EISSN: 1532-818X</identifier><identifier>DOI: 10.1016/j.amjoto.2006.06.015</identifier><identifier>PMID: 17362809</identifier><identifier>CODEN: AJOTDP</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Carcinoma, Squamous Cell - blood ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - radiotherapy ; Female ; Humans ; Immunoenzyme Techniques - methods ; Laryngeal Neoplasms - blood ; Laryngeal Neoplasms - mortality ; Laryngeal Neoplasms - radiotherapy ; Male ; Medical sciences ; Middle Aged ; Otolaryngology ; Otorhinolaryngology. Stomatology ; Pharyngeal Neoplasms - blood ; Pharyngeal Neoplasms - mortality ; Pharyngeal Neoplasms - radiotherapy ; Surgery ; Tumors ; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology ; Vascular Endothelial Growth Factor A - blood</subject><ispartof>American journal of otolaryngology, 2007-03, Vol.28 (2), p.73-77</ispartof><rights>2007</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Limited 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33</citedby><cites>FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19187326$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17362809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gisterek, Iwona, MD, PhD</creatorcontrib><creatorcontrib>Sedlaczek, Paweł, PhD</creatorcontrib><creatorcontrib>Kornafel, Jan</creatorcontrib><creatorcontrib>Harłoziñska-Szmyrka, Antonina</creatorcontrib><creatorcontrib>Łacko, Aleksandra, MD, PhD</creatorcontrib><title>Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy</title><title>American journal of otolaryngology</title><addtitle>Am J Otolaryngol</addtitle><description>Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative sandwich enzyme immunoassay technique. Most (25 patients [68%]) of the studied population were found to have high pretreatment VEGF concentration (of &gt;700 pg/mL; median, 796.3 pg/mL). During radiotherapy, after receiving the total dose of 40 Gy, the median level of serum VEGF remained unchanged (795.2 pg/mL). Regardless of the treatment results, 2 months after completing irradiation the median VEGF level decreased to 448.9 pg/mL, and the difference between pre- and posttreatment medians was statistically significant ( P &lt; .05). No association between pretreatment serum VEGF concentrations and the size of tumor, lymph node status, and patients' age was found. The findings that radiotherapy produces serum VEGF decline in primary pharyngeal and laryngeal carcinomas ( P = .065) may be related to the blocking effect of radiation on local angiogenesis.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Squamous Cell - blood</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoenzyme Techniques - methods</subject><subject>Laryngeal Neoplasms - blood</subject><subject>Laryngeal Neoplasms - mortality</subject><subject>Laryngeal Neoplasms - radiotherapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Otolaryngology</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Pharyngeal Neoplasms - blood</subject><subject>Pharyngeal Neoplasms - mortality</subject><subject>Pharyngeal Neoplasms - radiotherapy</subject><subject>Surgery</subject><subject>Tumors</subject><subject>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><subject>Vascular Endothelial Growth Factor A - blood</subject><issn>0196-0709</issn><issn>1532-818X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkluL1DAUx4Mo7jj6DUQCom8dc-klfRGWxRss-LAKvoUz6elOatt0k3SXefeDm9LBgX0RAiHhd27__yHkNWc7znj5odvB0LnodoKxcrccXjwhG15IkSmufj0lG8brMmMVqy_IixA6xpjMZfGcXPBKlkKxekP-3KCfB3oPwcw9eIpj4-IBews9vfXuIR5oCyY6T-1IJ4gWxxjog03_0wH8cbzFRMLY0P7fK9zNMLg5UIN9Tw14Y0c3AI0eIWKzRnto7FLJw3R8SZ610Ad8dbq35OfnTz-uvmbX3798u7q8zkxeyZiBUkqqPBe4byWv0gCNaop9rQSHUiUVSiZVpaSplQGoc5AlJqqqQWFe7KXckvdr3sm7uxlD1IMNS5MwYupXV0yUqkjibMnbR2DnZj-m3jRnkotc8Gqh8pUy3oXgsdWTt0OSIUF68Uh3evVILx7p5SR7tuTNKfm8H7A5B51MScC7E5Bcgb71MBobzlzNVSVFmbiPK4dJs3uLXgeT_DHYWI8m6sbZ_3XyOIHp7WhTzd94xHCeWQehmb5Z9mlZJ1YyxoUU8i9uUsfC</recordid><startdate>20070301</startdate><enddate>20070301</enddate><creator>Gisterek, Iwona, MD, PhD</creator><creator>Sedlaczek, Paweł, PhD</creator><creator>Kornafel, Jan</creator><creator>Harłoziñska-Szmyrka, Antonina</creator><creator>Łacko, Aleksandra, MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>20070301</creationdate><title>Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy</title><author>Gisterek, Iwona, MD, PhD ; Sedlaczek, Paweł, PhD ; Kornafel, Jan ; Harłoziñska-Szmyrka, Antonina ; Łacko, Aleksandra, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Squamous Cell - blood</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoenzyme Techniques - methods</topic><topic>Laryngeal Neoplasms - blood</topic><topic>Laryngeal Neoplasms - mortality</topic><topic>Laryngeal Neoplasms - radiotherapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Otolaryngology</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Pharyngeal Neoplasms - blood</topic><topic>Pharyngeal Neoplasms - mortality</topic><topic>Pharyngeal Neoplasms - radiotherapy</topic><topic>Surgery</topic><topic>Tumors</topic><topic>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</topic><topic>Vascular Endothelial Growth Factor A - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gisterek, Iwona, MD, PhD</creatorcontrib><creatorcontrib>Sedlaczek, Paweł, PhD</creatorcontrib><creatorcontrib>Kornafel, Jan</creatorcontrib><creatorcontrib>Harłoziñska-Szmyrka, Antonina</creatorcontrib><creatorcontrib>Łacko, Aleksandra, MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>American journal of otolaryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gisterek, Iwona, MD, PhD</au><au>Sedlaczek, Paweł, PhD</au><au>Kornafel, Jan</au><au>Harłoziñska-Szmyrka, Antonina</au><au>Łacko, Aleksandra, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy</atitle><jtitle>American journal of otolaryngology</jtitle><addtitle>Am J Otolaryngol</addtitle><date>2007-03-01</date><risdate>2007</risdate><volume>28</volume><issue>2</issue><spage>73</spage><epage>77</epage><pages>73-77</pages><issn>0196-0709</issn><eissn>1532-818X</eissn><coden>AJOTDP</coden><abstract>Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative sandwich enzyme immunoassay technique. Most (25 patients [68%]) of the studied population were found to have high pretreatment VEGF concentration (of &gt;700 pg/mL; median, 796.3 pg/mL). During radiotherapy, after receiving the total dose of 40 Gy, the median level of serum VEGF remained unchanged (795.2 pg/mL). Regardless of the treatment results, 2 months after completing irradiation the median VEGF level decreased to 448.9 pg/mL, and the difference between pre- and posttreatment medians was statistically significant ( P &lt; .05). No association between pretreatment serum VEGF concentrations and the size of tumor, lymph node status, and patients' age was found. The findings that radiotherapy produces serum VEGF decline in primary pharyngeal and laryngeal carcinomas ( P = .065) may be related to the blocking effect of radiation on local angiogenesis.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>17362809</pmid><doi>10.1016/j.amjoto.2006.06.015</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0196-0709
ispartof American journal of otolaryngology, 2007-03, Vol.28 (2), p.73-77
issn 0196-0709
1532-818X
language eng
recordid cdi_proquest_miscellaneous_70268517
source ScienceDirect Journals
subjects Adult
Aged
Biological and medical sciences
Carcinoma, Squamous Cell - blood
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - radiotherapy
Female
Humans
Immunoenzyme Techniques - methods
Laryngeal Neoplasms - blood
Laryngeal Neoplasms - mortality
Laryngeal Neoplasms - radiotherapy
Male
Medical sciences
Middle Aged
Otolaryngology
Otorhinolaryngology. Stomatology
Pharyngeal Neoplasms - blood
Pharyngeal Neoplasms - mortality
Pharyngeal Neoplasms - radiotherapy
Surgery
Tumors
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Vascular Endothelial Growth Factor A - blood
title Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T00%3A35%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20vascular%20endothelial%20growth%20factor%20in%20patients%20with%20pharyngeal%20and%20laryngeal%20squamous%20cell%20carcinoma%20treated%20with%20radiotherapy&rft.jtitle=American%20journal%20of%20otolaryngology&rft.au=Gisterek,%20Iwona,%20MD,%20PhD&rft.date=2007-03-01&rft.volume=28&rft.issue=2&rft.spage=73&rft.epage=77&rft.pages=73-77&rft.issn=0196-0709&rft.eissn=1532-818X&rft.coden=AJOTDP&rft_id=info:doi/10.1016/j.amjoto.2006.06.015&rft_dat=%3Cproquest_cross%3E70268517%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1031242177&rft_id=info:pmid/17362809&rfr_iscdi=true